• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
Journal of Advanced Pharmacy Research
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 9 (2025)
Volume Volume 8 (2024)
Volume Volume 7 (2023)
Volume Volume 6 (2022)
Volume Volume 5 (2021)
Issue Issue 4
Issue Issue 3
Issue Issue 2
Issue Issue 1
Volume Volume 4 (2020)
Volume Volume 3 (2019)
Volume Volume 2 (2018)
Volume Volume 1 (2017)
Helali, A., Sarg, M., Elzoghbi, M. (2021). Utility of Activated Nitriles in the Synthesis of some New Pyridine and Fused Pyridine Derivatives with Anticancer Activity. Journal of Advanced Pharmacy Research, 5(1), 180-201. doi: 10.21608/aprh.2020.37889.1114
Aisha Helali; Marwa Sarg; Mona Elzoghbi. "Utility of Activated Nitriles in the Synthesis of some New Pyridine and Fused Pyridine Derivatives with Anticancer Activity". Journal of Advanced Pharmacy Research, 5, 1, 2021, 180-201. doi: 10.21608/aprh.2020.37889.1114
Helali, A., Sarg, M., Elzoghbi, M. (2021). 'Utility of Activated Nitriles in the Synthesis of some New Pyridine and Fused Pyridine Derivatives with Anticancer Activity', Journal of Advanced Pharmacy Research, 5(1), pp. 180-201. doi: 10.21608/aprh.2020.37889.1114
Helali, A., Sarg, M., Elzoghbi, M. Utility of Activated Nitriles in the Synthesis of some New Pyridine and Fused Pyridine Derivatives with Anticancer Activity. Journal of Advanced Pharmacy Research, 2021; 5(1): 180-201. doi: 10.21608/aprh.2020.37889.1114

Utility of Activated Nitriles in the Synthesis of some New Pyridine and Fused Pyridine Derivatives with Anticancer Activity

Article 2, Volume 5, Issue 1, January 2021, Page 180-201  XML PDF (786.74 K)
Document Type: Research Article
DOI: 10.21608/aprh.2020.37889.1114
View on SCiNiTO View on SCiNiTO
Authors
Aisha Helali1; Marwa Sarg2; Mona Elzoghbi email orcid 3
1Organic Chemistry Department, Faculty of Science (Girls) Al-Azhar University, Cairo, Egypt
2Pharmaceutical Organic Chemistry Department, Faculty of Pharmacy (Girls) Al-Azhar University, Cairo, Egypt.
3Pharmaceutical Chemistry Department, Faculty of Pharmacy, Menoufia University, Menoufia, Egypt.
Abstract
Objective: This study aimed synthesis of pyridine and fused pyridine derivatives based on the importance of these heterocycles as anticancer. Method: Novel pyridine and fused pyridine derivatives 3-35 were synthesized through different chemical reactions. Results: Structures of these compounds were confirmed by spectral and elemental analyses. The obtained compounds were evaluated for their in vitro antitumor activity against liver HepG2 and breast MCF-7 cancer cell lines compared to the reference drug (5-fluorouracil). Conclusion: Compounds 4, 12, 13, 19, 21, 28 and 29 were found to be the most active against both cell lines exhibiting IC50 values ranging from 3.05-11.50 μg/mL and 2.87-6.23 μg/mL against HepG-2 and MCF-7 cell lines; respectively
Keywords
Pyridine; Anticancer; HepG2; MCF-7
Main Subjects
Section B: Pharmaceutical Analytical & Organic Chemistry, Medicinal & Biochemistry
Statistics
Article View: 399
PDF Download: 641
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.